Home » All » Stock Forecast » Crescent Biopharma Inc. Common Stock Forecast

Crescent Biopharma Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▲ +13.28%Market Cap $677.07M · Technical analysis Bullish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$25.07 ▲ +2.03%	Yesterday	$24.36 ▼ -0.85%	Tomorrow's Crescent Biopharma Inc. Common Stock (CBIO) setup is anchored to $24.57 and targets $25.07 (+2.03%). The near-term read is upside; watch $25.31 / $23.83 because daily realized volatility is about 8.00%.
Tomorrow's Crescent Biopharma Inc. Common Stock (CBIO) setup is anchored to $24.57 and targets $25.07 (+2.03%). The near-term read is upside; watch $25.31 / $23.83 because daily realized volatility is about 8.00%.
Week	$26.12 ▲ +6.31%	Last Week	$23.92 ▼ -2.65%	The 7-day Crescent Biopharma Inc. Common Stock model moves from $23.92 to $26.12 (+6.31%). It gives upside momentum context for this stock, so breaks around $25.31 / $23.83 matter more than a single tick.
The 7-day Crescent Biopharma Inc. Common Stock model moves from $23.92 to $26.12 (+6.31%). It gives upside momentum context for this stock, so breaks around $25.31 / $23.83 matter more than a single tick.
Month	$27.87 ▲ +13.45%	Last Month	$23.18 ▼ -5.65%	The 1-month Crescent Biopharma Inc. Common Stock target is $27.87 (+13.45%), compared with the live reference near $24.57. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Crescent Biopharma Inc. Common Stock target is $27.87 (+13.45%), compared with the live reference near $24.57. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$30.50 ▲ +24.14%	Last Year	$22.08 ▼ -10.14%	The 1-year Crescent Biopharma Inc. Common Stock scenario points to $30.50 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Crescent Biopharma Inc. Common Stock scenario points to $30.50 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$36.66 ▲ +49.20%	5 Years Ago	$19.49 ▼ -20.66%	The 5-year Crescent Biopharma Inc. Common Stock view is $36.66 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Crescent Biopharma Inc. Common Stock view is $36.66 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$25.07▲ +2.03%

Yesterday$24.36▼ -0.85%

Tomorrow's Crescent Biopharma Inc. Common Stock (CBIO) setup is anchored to $24.57 and targets $25.07 (+2.03%). The near-term read is upside; watch $25.31 / $23.83 because daily realized volatility is about 8.00%.

Week$26.12▲ +6.31%

Last Week$23.92▼ -2.65%

The 7-day Crescent Biopharma Inc. Common Stock model moves from $23.92 to $26.12 (+6.31%). It gives upside momentum context for this stock, so breaks around $25.31 / $23.83 matter more than a single tick.

Month$27.87▲ +13.45%

Last Month$23.18▼ -5.65%

The 1-month Crescent Biopharma Inc. Common Stock target is $27.87 (+13.45%), compared with the live reference near $24.57. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$30.50▲ +24.14%

Last Year$22.08▼ -10.14%

The 1-year Crescent Biopharma Inc. Common Stock scenario points to $30.50 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$36.66▲ +49.20%

5 Years Ago$19.49▼ -20.66%

The 5-year Crescent Biopharma Inc. Common Stock view is $36.66 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$24.57	Mid
Daily Change	+13.28%	Above
Volatility Cap	20.0%	Mid
Confidence	85%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$24.57

Daily Change+13.28%

Market Cap$677.07M

Sourcenasdaq-screener

Current	$24.57	Daily Change	+13.28%
Market Cap	$677.07M	Source	nasdaq-screener

Support & Resistance Levels

$23.83Support 1

$24.57Current

$25.31Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$24.57Live reference price

Used as the anchor for generated forecast calculations.

Next Month$27.87Model projection+13.45%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

85%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

85%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CBIO today

Bullish Scenario

$25.80

+5.00% from current

Target Price$25.80

ScenarioUpside momentum

Probability62%

Base Scenario

$27.87

+13.45%

Target Price$27.87

ScenarioCapped drift

Probability70%

Bearish Scenario

$23.34

-5.00% from current

Target Price$23.34

ScenarioVolatility drawdown

Probability20%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 79/100

24H drift+2.03%

7D drift+6.31%

30D drift+13.45%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 75/100

1M outlook+13.45%

1Y outlook+24.14%

5Y outlook+49.20%

Frequently Asked Questions

Q What is the Crescent Biopharma Inc. Common Stock (CBIO) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Crescent Biopharma Inc. Common Stock is projected near $25.07 versus the current reference around $24.57. That implies a modeled move of +2.03% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CBIO?

The weekly Crescent Biopharma Inc. Common Stock model points to $26.12, which maps to an expected drift of +6.31% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Crescent Biopharma Inc. Common Stock 1-month and 1-year targets?

The Crescent Biopharma Inc. Common Stock 1-month target is $27.87 (+13.45%), while the 1-year target is $30.50 (+24.14%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Crescent Biopharma Inc. Common Stock 5-year scenario differ from short-term rows?

The Crescent Biopharma Inc. Common Stock long-horizon scenario sits near $36.66 with a modeled change of +49.20%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CBIO support and resistance zones right now?

For Crescent Biopharma Inc. Common Stock, nearest resistance is around $23.83, while nearest support is around $25.31. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Crescent Biopharma Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.